174 related articles for article (PubMed ID: 11346462)
1. A ferulic acid derivative, ethyl 3-(4'-geranyloxy-3-methoxyphenyl)-2-propenoate, as a new candidate chemopreventive agent for colon carcinogenesis in the rat.
Han BS; Park CB; Takasuka N; Naito A; Sekine K; Nomura E; Taniguchi H; Tsuno T; Tsuda H
Jpn J Cancer Res; 2001 Apr; 92(4):404-9. PubMed ID: 11346462
[TBL] [Abstract][Full Text] [Related]
2. Influence of ethyl 3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate (EGMP) on early stage colon carcinogenesis in rats treated with azoxymethane (AOM).
Tsuda H; Park CB; Takasuka N; Baba-Toriyama H; Sekine K; Moore MA; Nomura E; Taniguchi H
Anticancer Res; 1999; 19(5A):3779-82. PubMed ID: 10625958
[TBL] [Abstract][Full Text] [Related]
3. A novel geranylated derivative, ethyl 3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate, synthesized from ferulic acid suppresses carcinogenesis and inducible nitric oxide synthase in rat tongue.
Tanaka T; Kohno H; Nomura E; Taniguchi H; Tsuno T; Tsuda H
Oncology; 2003; 64(2):166-75. PubMed ID: 12566915
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effects of ferulic acid on oral and rice germ on large bowel carcinogenesis.
Mori H; Kawabata K; Yoshimi N; Tanaka T; Murakami T; Okada T; Murai H
Anticancer Res; 1999; 19(5A):3775-8. PubMed ID: 10625957
[TBL] [Abstract][Full Text] [Related]
5. Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hara A; Yamahara J; Mori H
Cancer Res; 1995 Mar; 55(6):1277-82. PubMed ID: 7882322
[TBL] [Abstract][Full Text] [Related]
6. Modifying effects of ferulic acid on azoxymethane-induced colon carcinogenesis in F344 rats.
Kawabata K; Yamamoto T; Hara A; Shimizu M; Yamada Y; Matsunaga K; Tanaka T; Mori H
Cancer Lett; 2000 Aug; 157(1):15-21. PubMed ID: 10893437
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM).
Kim DJ; Kang JS; Ahn B; Kim KS; Park KH; Choi KS; Surh YJ; Kim ND
Cancer Lett; 2001 May; 166(2):125-33. PubMed ID: 11311484
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of d-limonene on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.
Kawamori T; Tanaka T; Hirose Y; Ohnishi M; Mori H
Carcinogenesis; 1996 Feb; 17(2):369-72. PubMed ID: 8625465
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
10. Suppression of azoxymethane-induced rat colon aberrant crypt foci by dietary protocatechuic acid.
Kawamori T; Tanaka T; Kojima T; Suzui M; Ohnishi M; Mori H
Jpn J Cancer Res; 1994 Jul; 85(7):686-91. PubMed ID: 8071110
[TBL] [Abstract][Full Text] [Related]
11. Suppressing effect of perilla oil on azoxymethane-induced foci of colonic aberrant crypts in rats.
Onogi N; Okuno M; Komaki C; Moriwaki H; Kawamori T; Tanaka T; Mori H; Muto Y
Carcinogenesis; 1996 Jun; 17(6):1291-6. PubMed ID: 8681445
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.
Wargovich MJ; Jimenez A; McKee K; Steele VE; Velasco M; Woods J; Price R; Gray K; Kelloff GJ
Carcinogenesis; 2000 Jun; 21(6):1149-55. PubMed ID: 10837003
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.
Tanaka T; Kawabata K; Kakumoto M; Makita H; Matsunaga K; Mori H; Satoh K; Hara A; Murakami A; Koshimizu K; Ohigashi H
Jpn J Cancer Res; 1997 Sep; 88(9):821-30. PubMed ID: 9369929
[TBL] [Abstract][Full Text] [Related]
14. Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.
Kawamori T; Takahashi M; Watanabe K; Ohta T; Nakatsugi S; Sugimura T; Wakabayashi K
Cancer Lett; 2000 Jan; 148(1):33-7. PubMed ID: 10680590
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis.
Tanaka T; Kojima T; Suzui M; Mori H
Cancer Res; 1993 Sep; 53(17):3908-13. PubMed ID: 8358716
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of azoxymethane-induced rat aberrant crypt foci by dietary zerumbone isolated from Zingiber zerumbet.
Tanaka T; Shimizu M; Kohno H; Yoshitani S; Tsukio Y; Murakami A; Safitri R; Takahashi D; Yamamoto K; Koshimizu K; Ohigashi H; Mori H
Life Sci; 2001 Sep; 69(16):1935-45. PubMed ID: 11693274
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.
Yoshimi N; Kawabata K; Hara A; Matsunaga K; Yamada Y; Mori H
Jpn J Cancer Res; 1997 Nov; 88(11):1044-51. PubMed ID: 9439679
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon.
Chiampanichayakul S; Kataoka K; Arimochi H; Thumvijit S; Kuwahara T; Nakayama H; Vinitketkumnuen U; Ohnishi Y
J Med Invest; 2001 Feb; 48(1-2):88-96. PubMed ID: 11286022
[TBL] [Abstract][Full Text] [Related]
20. Suppression of azoxymethane-induced colonic aberrant crypt foci by dietary exposure to a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)ethenyl)-2(5H)-furanone, in rats.
Kawamori T; Tanaka T; Hirose Y; Satoh K; Hara A; Torihara M; Tamai Y; Yamahara J; Mori H
Cancer Lett; 1995 Jun; 92(2):159-65. PubMed ID: 7600526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
